RRC ID 44339
著者 Niino S, Nakamura Y, Hirabayashi Y, Nagano-Ito M, Ichikawa S.
タイトル A small molecule inhibitor of Bcl-2, HA14-1, also inhibits ceramide glucosyltransferase.
ジャーナル Biochem Biophys Res Commun
Abstract HA14-1 is a Bcl-2 inhibitor that is widely used for studies of apoptosis. In the course of searching for a ceramide glucosyltransferase inhibitor that catalyzes the first glycosylation step of glycosphingolipid synthesis, we unexpectedly found that HA-14-1 also has the ability to inhibit ceramide glucosyltransferase. The IC50 value of HA14-1 against ceramide glucosyltransferase is 4.5μM, which is lower than that reported for Bcl-2 in vitro. Kinetic analyses revealed that HA14-1 is a competitive and mixed-type inhibitor with respect to C6-NBD-ceramide and UDP-glucose, respectively.
巻・号 433(2)
ページ 170-4
公開日 2013-4-5
DOI 10.1016/j.bbrc.2013.02.052
PII S0006-291X(13)00312-4
PMID 23485465
MeSH 4-Chloro-7-nitrobenzofurazan / analogs & derivatives 4-Chloro-7-nitrobenzofurazan / pharmacology Animals Apoptosis / drug effects Benzopyrans / pharmacology* Cell Line Ceramides / metabolism Ceramides / pharmacology Drug Evaluation, Preclinical / methods Enzyme Inhibitors / pharmacology Glucosyltransferases / antagonists & inhibitors* Glucosyltransferases / metabolism Humans Inhibitory Concentration 50 Kinetics Melanoma, Experimental / drug therapy Melanoma, Experimental / metabolism Mice Nitriles / pharmacology* Proto-Oncogene Proteins c-bcl-2 / antagonists & inhibitors
IF 2.985
引用数 4
WOS 分野 BIOPHYSICS BIOCHEMISTRY & MOLECULAR BIOLOGY
リソース情報
ヒト・動物細胞